捕获和监测未治疗和治疗的终末期肾脏疾病、肾脏替代治疗方式和结果的全球差异

IF 19.3 2区 医学 Q1 UROLOGY & NEPHROLOGY Kidney International Supplements Pub Date : 2020-03-01 DOI:10.1016/j.kisu.2019.11.001
Roberto Pecoits-Filho , Ikechi G. Okpechi , Jo-Ann Donner , David C.H. Harris , Harith M. Aljubori , Aminu K. Bello , Ezequiel Bellorin-Font , Fergus J. Caskey , Allan Collins , Alfonso M. Cueto-Manzano , John Feehally , Bak Leong Goh , Kitty J. Jager , Masaomi Nangaku , Muhibur Rahman , Manisha Sahay , Abdulkarim Saleh , Laura Sola , Rumeyza Turan Kazancioglu , Rachael C. Walker , David W. Johnson
{"title":"捕获和监测未治疗和治疗的终末期肾脏疾病、肾脏替代治疗方式和结果的全球差异","authors":"Roberto Pecoits-Filho ,&nbsp;Ikechi G. Okpechi ,&nbsp;Jo-Ann Donner ,&nbsp;David C.H. Harris ,&nbsp;Harith M. Aljubori ,&nbsp;Aminu K. Bello ,&nbsp;Ezequiel Bellorin-Font ,&nbsp;Fergus J. Caskey ,&nbsp;Allan Collins ,&nbsp;Alfonso M. Cueto-Manzano ,&nbsp;John Feehally ,&nbsp;Bak Leong Goh ,&nbsp;Kitty J. Jager ,&nbsp;Masaomi Nangaku ,&nbsp;Muhibur Rahman ,&nbsp;Manisha Sahay ,&nbsp;Abdulkarim Saleh ,&nbsp;Laura Sola ,&nbsp;Rumeyza Turan Kazancioglu ,&nbsp;Rachael C. Walker ,&nbsp;David W. Johnson","doi":"10.1016/j.kisu.2019.11.001","DOIUrl":null,"url":null,"abstract":"<div><p><span>A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that &gt;3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust </span>health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Pages e3-e9"},"PeriodicalIF":19.3000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.001","citationCount":"37","resultStr":"{\"title\":\"Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes\",\"authors\":\"Roberto Pecoits-Filho ,&nbsp;Ikechi G. Okpechi ,&nbsp;Jo-Ann Donner ,&nbsp;David C.H. Harris ,&nbsp;Harith M. Aljubori ,&nbsp;Aminu K. Bello ,&nbsp;Ezequiel Bellorin-Font ,&nbsp;Fergus J. Caskey ,&nbsp;Allan Collins ,&nbsp;Alfonso M. Cueto-Manzano ,&nbsp;John Feehally ,&nbsp;Bak Leong Goh ,&nbsp;Kitty J. Jager ,&nbsp;Masaomi Nangaku ,&nbsp;Muhibur Rahman ,&nbsp;Manisha Sahay ,&nbsp;Abdulkarim Saleh ,&nbsp;Laura Sola ,&nbsp;Rumeyza Turan Kazancioglu ,&nbsp;Rachael C. Walker ,&nbsp;David W. Johnson\",\"doi\":\"10.1016/j.kisu.2019.11.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that &gt;3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust </span>health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.</p></div>\",\"PeriodicalId\":48895,\"journal\":{\"name\":\"Kidney International Supplements\",\"volume\":\"10 1\",\"pages\":\"Pages e3-e9\"},\"PeriodicalIF\":19.3000,\"publicationDate\":\"2020-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.001\",\"citationCount\":\"37\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney International Supplements\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2157171619300152\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney International Supplements","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2157171619300152","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 37

摘要

最近发现,接受肾脏替代治疗(KRT)的终末期肾病(ESKD)患者与需要肾脏替代治疗的患者之间存在巨大差距,据估计,全世界约有一半至四分之三的ESKD患者可能因无法接受KRT而过早死亡。这一估计与之前的一份报告一致,该报告估计,世界上每年有300万人因无法获得KRT而死亡。本综述讨论了治疗和未治疗ESKD和KRT模式和结果差异的原因,并提出了通过建立健全的卫生信息系统来缩小全球KRT差距的策略,以指导资源分配到需要的地区,为KRT服务规划提供信息,促进政策制定,并监测KRT健康结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes

A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Kidney International Supplements
Kidney International Supplements UROLOGY & NEPHROLOGY-
CiteScore
11.80
自引率
0.00%
发文量
13
期刊介绍: Kidney International Supplements is published on behalf of the International Society of Nephrology (ISN) and comes complimentary as part of a subscription to Kidney International. Kidney International Supplements is a peer-reviewed journal whose focus is sponsored, topical content of interest to the nephrology community.
期刊最新文献
Editorial Board Table of Contents Variations in kidney care management and access: regional assessments of the 2023 International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) Update on variability in organization and structures of kidney care across world regions Capacity for the management of kidney failure in the International Society of Nephrology Newly Independent States and Russia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1